<TEXT>&#2;<DATELINE>2009-02-28</DATELINE><TITLE>Complement Receptor 1: Disease associations and therapeutic implications</TITLE><BODY>Abstract Exaggerated complement activation is a key event in the pathogenesis of a range of autoimmune and inflammatory diseases. Complement Receptor 1 (CR1) has emerged as a molecule of immense interest in gaining insight to the susceptibility, pathophysiology, diagnosis, prognosis and therapy of such diseases. This review brings forth a composite view of the current understanding on the structure, functions, genetics, disease associations and therapeutic implications of CR1.&#3;</BODY></TEXT>